A Phase I Study of ZN-d5 in Chinese Subjects With Non-Hodgkin Lymphoma

NCT05127811 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

8

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor's decision

Conditions

Non-Hodgkin Lymphoma

Interventions

DRUG: ZN-d5

Sponsor

Zentera Therapeutics HK Limited